Literature DB >> 23188196

Kawasaki disease: basic and pathological findings.

Kei Takahashi1, Toshiaki Oharaseki2, Yuki Yokouchi2, Shiro Naoe3, Tsutomu Saji4.   

Abstract

Kawasaki disease (KD) is considered to be a kind of systemic vasculitis syndrome. It most frequently affects infants and young children and primarily invades medium-sized muscular arteries, including the coronary arteries. The etiology of KD is unknown, but epidemiological data suggest involvement of infectious agents, such as bacteria and viruses, in the onset of KD. In addition, host genetics underlie the disease's pathogenesis. Histologically, coronary arteritis begins 6-8 days after KD onset, and inflammation of all layers of the artery rapidly ensues. The inflammation spreads completely around the artery, resulting in severe damage to structural components. Then, the artery begins to dilate. KD arteritis is characterized by inflammation consisting of marked accumulation of monocytes/macrophages. Aberrant activation of monocytes/macrophages is thought to be involved in the formation of vascular lesions. Inflammatory-cell infiltration persists until about the 25th day of the disease, after which the inflammatory cells gradually decrease in number. Lesions in all arteries are relatively synchronous, as they evolve from acute to chronic injury. If a giant aneurysm remains or vessel recanalization occurs after thrombotic occlusion of an aneurysm, remodeling of the vascular structure, sometimes including even reocclusion, continues even in the remote stage.

Entities:  

Mesh:

Year:  2012        PMID: 23188196     DOI: 10.1007/s10157-012-0734-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  20 in total

1.  Oligoclonal IgA response in the vascular wall in acute Kawasaki disease.

Authors:  A H Rowley; S T Shulman; B T Spike; C A Mask; S C Baker
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 2.  Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).

Authors:  B H Landing; E J Larson
Journal:  Am J Cardiovasc Pathol       Date:  1987

3.  Coronary findings post Kawasaki disease in children who died of other causes.

Authors:  S Naoe; K Takahashi; H Masuda; N Tanaka
Journal:  Prog Clin Biol Res       Date:  1987

4.  IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease.

Authors:  A H Rowley; S T Shulman; C A Mask; L S Finn; M Terai; S C Baker; C A Galliani; K Takahashi; S Naoe; M B Kalelkar; S E Crawford
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

5.  Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis.

Authors:  K Takahashi; T Oharaseki; S Naoe
Journal:  Pediatr Cardiol       Date:  2001 Mar-Apr       Impact factor: 1.655

6.  Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions.

Authors:  N Tanaka; S Naoe; H Masuda; T Ueno
Journal:  Acta Pathol Jpn       Date:  1986-10

7.  Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody.

Authors:  Anne H Rowley; Susan C Baker; Stanford T Shulman; Francesca L Garcia; Judith A Guzman-Cottrill; Pauline Chou; Masaru Terai; Tomisaku Kawasaki; Mitra B Kalelkar; Susan E Crawford
Journal:  J Infect Dis       Date:  2004-07-16       Impact factor: 5.226

8.  Regression of aneurysms in Kawasaki disease: a pathological study.

Authors:  Y Sasaguri; H Kato
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

9.  Characterization of T cell repertoire changes in acute Kawasaki disease.

Authors:  J Abe; B L Kotzin; C Meissner; M E Melish; M Takahashi; D Fulton; F Romagne; B Malissen; D Y Leung
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

10.  RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease.

Authors:  Anne H Rowley; Susan C Baker; Stanford T Shulman; Francesca L Garcia; Linda M Fox; Ian M Kos; Susan E Crawford; Pierre A Russo; Rashid Hammadeh; Kei Takahashi; Jan M Orenstein
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

View more
  19 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.

Authors:  Youngho Lee; Daiko Wakita; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Ganghua Huang; Thomas J A Lehman; Michael C Fishbein; Hal M Hoffman; Timothy R Crother; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

Review 3.  The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.

Authors:  Xiaochuan Xie; Xiaohan Shi; Meilin Liu
Journal:  Pediatr Cardiol       Date:  2017-11-02       Impact factor: 1.655

4.  CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.

Authors:  Magali Noval Rivas; Youngho Lee; Daiko Wakita; Norika Chiba; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Michael C Fishbein; Thomas J A Lehman; Timothy R Crother; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

5.  Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin.

Authors:  Adriana H Tremoulet; Sonia Jain; Jane C Burns
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-13       Impact factor: 0.694

6.  Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease.

Authors:  Fikri Demir; Cem Karadeniz; Rahmi Özdemir; Yılmaz Yozgat; Kübra Çelegen; Utku Karaaslan; Mustafa Demirol; Timur Meşe; Nurettin Ünal
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

7.  Giant coronary artery aneurysm associated with Kawasaki disease showing progressive dilation over 30 years.

Authors:  Tao Fujioka; Nanae Asakawa; Toshihiko Suzuki; Jotaro Kobayashi; Kei Takahashi; Keiji Tsuchiya
Journal:  J Cardiol Cases       Date:  2021-02-11

8.  Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.

Authors:  Fu-Chen Huang; Ho-Chang Kuo; Ying-Hsien Huang; Hong-Ren Yu; Sung-Chou Li; Hsing-Chun Kuo
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-09       Impact factor: 2.483

9.  Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.

Authors:  Yukako Yoshikane; Yoshiaki Okuma; Tatsuki Miyamoto; Junichi Hashimoto; Ryuji Fukazawa; Taichi Kato; Atsuhito Takeda; Kenji Suda; Takeji Matsushita; Michiaki Hiroe; Kyoko Imanaka-Yoshida
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-05       Impact factor: 3.054

10.  The transcriptional profile of coronary arteritis in Kawasaki disease.

Authors:  Anne H Rowley; Kristine M Wylie; Kwang-Youn A Kim; Adam J Pink; Amy Yang; Rebecca Reindel; Susan C Baker; Stanford T Shulman; Jan M Orenstein; Mark W Lingen; George M Weinstock; Todd N Wylie
Journal:  BMC Genomics       Date:  2015-12-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.